FinanceJanuary 30, 2026 Starmer, Carney, and Orsi Journey to Beijing: Exploring New Opportunities and Deals! TAGS: AstraZeneca PLCBeijingbusiness newsChinaDonald TrumpForeign policyKeir StarmerMark CarneyMarket InsiderMarketsStock marketsUnited StatesXi Jinping Editorial content by Avery Johnson Related posts Nvidias U.S.-Approved AI Chips for… Unmissable After-Hours Stock Movers: AKAM,… ETF Flows Dip: What It… Could AI Disruption Be the… Mike Novogratz Declares the End… Discover Luxury: Luckin Coffee Launches… Bitcoin Struggles for a Second… Musk Shifts Focus: How These…